ENANTA PHARMACEUTICALS INC

Nasdaq:ENTA

Pharmaceutical Preparations·WATERTOWN, MA

CEO

Luly Jay R.

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q4 2025	12/31/25	2/11/26	→
10-K	FY 2025	9/30/25	11/19/25	→
10-Q	Q2 2025	6/30/25	8/13/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-Q	Q4 2024	12/31/24	2/12/25	→
10-K	FY 2024	9/30/24	11/27/24	→
↓

Earnings Releases (8-K)

44 shown

Filed	Period
2/9/26	Q2 FY2026	→
11/17/25	Q1 FY2026	→
8/11/25	Q4 FY2025	→
5/12/25	Q3 FY2025	→
2/10/25	Q2 FY2025	→
11/25/24	Q1 FY2025	→
↓

News (8-K)

36 shown

Filed	Type	Description
10/1/25	Other	Other Events	→
9/29/25	Reg FD	Regulation FD Disclosure	→
9/29/25	Reg FD	Regulation FD Disclosure	→
8/27/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
8/20/25	Reg FD	Regulation FD Disclosure	→
3/17/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

31 shown

Filed	Form	Description
2/11/26	S-3	S-3	→
1/26/26	ARS	ARS	→
10/1/25	424B5	424B5	→
9/30/25	424B5	424B5	→
5/14/25	S-8	S-8	→
1/27/25	ARS	ARS	→
↓

Filing History(809 filings)

TypeDateAccessionPeriodSize

EFFECT

Feb 20, 2026

9999999995-26-000642

—

1.6 KB

Feb 13, 2026

0002064832-26-000016STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 12, 2026

8.3 KB

Feb 13, 2026

0002064832-26-000014STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 12, 2026

8.3 KB

Feb 13, 2026

0002064832-26-000012STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 12, 2026

8.3 KB

Feb 13, 2026

0002064832-26-000010STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 12, 2026

8.3 KB

Feb 13, 2026

0002064832-26-000008STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 12, 2026

8.3 KB

Feb 13, 2026

0002064832-26-000006STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 12, 2026

8.3 KB

SCHEDULE 13G/A

Feb 13, 2026

0001172661-26-000711

—

10.9 KB

S-3

Feb 11, 2026

0001193125-26-046712S-3

—

604.6 KB

10-Q

Feb 11, 2026

0001193125-26-04650210-Q

Dec 31, 2025

9.1 MB

8-K

Feb 9, 2026

0001193125-26-0428128-K

Feb 9, 2026

397.6 KB

SCHEDULE 13G/A

Feb 5, 2026

0000908834-26-000042

—

56.8 KB

ARS

Jan 26, 2026

0001193125-26-022589ARS

Sep 30, 2025

11.5 MB

DEFA14A

Jan 26, 2026

0001193125-26-022585DEFA14A

—

113.8 KB

DEF 14A

Jan 26, 2026

0001193125-26-022558DEF 14A

Mar 11, 2026

3.3 MB

SCHEDULE 13G/A

Jan 20, 2026

0001104659-26-005096

—

18.3 KB

Dec 5, 2025

0002064832-25-000070STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Dec 5, 2025

5.5 KB

Dec 5, 2025

0002064832-25-000067STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Dec 5, 2025

5.4 KB

Dec 5, 2025

0002064832-25-000065STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Dec 5, 2025

5.3 KB

Dec 5, 2025

0002064832-25-000063STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Dec 5, 2025

5.3 KB

Dec 5, 2025

0002064832-25-000061STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Dec 5, 2025

5.4 KB

Dec 5, 2025

0002064832-25-000059STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Dec 5, 2025

5.3 KB

Dec 5, 2025

0002064832-25-000057STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Dec 5, 2025

5.3 KB

144

Dec 5, 2025

0001571211-25-000003

—

4.3 KB

Dec 3, 2025

0002064832-25-000053STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Dec 1, 2025

6.5 KB

25 filings shown

ENANTA PHARMACEUTICALS INC

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(809 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/13/26	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
2/13/26	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
2/13/26	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
2/13/26	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
2/13/26	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
2/13/26	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
↓

Filed	Form	Description
2/20/26	EFFECT	EFFECT	→
2/13/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/5/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/20/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
12/5/25	144	144	→
11/13/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓